Cite
HARVARD Citation
Hsu, B. et al. (n.d.). OP0025 Results from a multicenter, international, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-IL-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases. p. 61. [Online].